Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The employee options carry a $0.72 exercise price and vest over four years, subject to continuous service.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Milestone Pharmaceuticals (Nasdaq: MIST) granted 33,000 stock options as a hiring inducement for one new employee under its 2021 Inducement Plan.
The options were granted on November 2, 2026, at an exercise price of $0.72 per share, equal to the closing share price that day. They vest over four years: 25% on the first anniversary of the vesting commencement date, followed by 36 equal monthly installments. Vesting requires continuous service through each vesting date. The award was granted under Nasdaq Listing Rule 5635(c)(4).
Positive
- None.
Negative
- Minor point. Forward-looking: it has not happened yet and may not happen.33,000 options with a $0.72 per-share exercise price create potential dilution upon exercise.
Key Figures
- Options granted
- 33,000 options
- Inducement award to one new employee
- Exercise price
- $0.72 per share
- Equal to the closing price on the grant date
- Vesting schedule
- Four years; 25% after one year, then 36 monthly installments
- Subject to continuous service through each vesting date
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 33,000 options (the “Options”) to purchase the Company’s common shares, pursuant to the Company’s 2021 Inducement Plan (the “Plan”), previously approved by the Company’s Compensation Committee and the Board of Directors, as a material inducement to the hiring of one new employee.
The Options have a grant date of November 2, 2026, and an exercise price of
The Option awards are subject to the award holder’s continuous service through each vesting date and to the terms and conditions of the Plan and its standard forms of grant agreements thereunder.
The foregoing equity award was granted as an inducement material to the employees entering into employment with Milestone, in accordance with Nasdaq Listing Rule 5635(c)(4). The Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Milestone, or following a bona fide period of non-employment, as an inducement material to such individuals’ entering into employment with Milestone, pursuant to Nasdaq Listing Rule 5635(c)(4).
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is an emerging commercial-stage biopharmaceutical company advancing innovative cardiovascular medicines to benefit people living with certain heart conditions. Milestone’s lead product is CARDAMYST® (etripamil) nasal spray, a novel calcium channel blocker, which is FDA-approved for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. Etripamil is also in Phase 3 development for the control of symptomatic episodic attacks associated with AFib-RVR. https://milestonepharma.com/.
Contact:
Investor Relations
Kevin Gardner, kgardner@lifesciadvisors.com
Media Relations
Rebecca Novak, rnovak@milestonepharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Milestone Pharmaceuticals grant to its new employee?
Milestone granted 33,000 options to one new employee on November 2, 2026, with an exercise price of $0.72 per share. The exercise price equals the closing price of Milestone’s common shares on the grant date.
What is the vesting schedule for Milestone Pharmaceuticals' inducement options?
The options vest over four years, with 25% vesting on the first anniversary of the vesting commencement date and the balance in 36 successive equal monthly installments. The holder must remain in continuous service through each vesting date.